Krystal Biotech (KRYS) EBT (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.17% |
| Dec 31, 2025 | 6.60% |
| Sep 30, 2025 | 2.55% |
| Jun 30, 2025 | 7.29% |
| Mar 31, 2025 | -10.31% |
| Dec 31, 2024 | 63.29% |
| Sep 30, 2024 | 85.53% |
| Jun 30, 2024 | 1,621.57% |
| Mar 31, 2024 | -91.25% |
| Dec 31, 2023 | -86.80% |
| Sep 30, 2023 | 343.14% |
| Jun 30, 2023 | 26.68% |
| Mar 31, 2023 | -41.32% |
| Dec 31, 2022 | -7.38% |
| Sep 30, 2022 | -6.20% |
| Jun 30, 2022 | 43.74% |
| Mar 31, 2022 | -129.13% |
| Dec 31, 2021 | -39.88% |
| Sep 30, 2021 | 4.73% |
| Jun 30, 2021 | -3.48% |
| Mar 31, 2021 | -52.29% |
| Dec 31, 2020 | -8.04% |
| Sep 30, 2020 | -40.64% |
| Jun 30, 2020 | -27.93% |
| Mar 31, 2020 | 0.30% |
| Dec 31, 2019 | -25.40% |
| Sep 30, 2019 | 20.12% |
| Jun 30, 2019 | -30.09% |
| Mar 31, 2019 | -10.87% |
| Dec 31, 2018 | -34.59% |
| Sep 30, 2018 | -21.05% |
| Jun 30, 2018 | -5.86% |
| Mar 31, 2018 | -54.34% |
| Dec 31, 2017 | 73.58% |
| Sep 30, 2017 | -594.73% |
| Jun 30, 2017 | -53.64% |
| Mar 31, 2017 | 20.32% |
| Dec 31, 2016 | -92.55% |